Design of a Phase IIb, randomized, controlled, double-blind, multi-centre study to evaluate the efficacy, safety, and immunogenicity of the GMZ2 candidate malaria vaccine in Ugandan, Ghanaian, Burkinabe and Gabonese children aged 12-60 months

[摘要]

[发布日期] 2010-10-20

[关键词] Malaria;Aluminium Hydroxide;Parasite Density;Malaria Vaccine;Vaccine Antigen